SlideShare a Scribd company logo
Columbia University
School of Nursing
American Public Health Association October 24, 2001
Genetic/Genomic Competencies
for Public Health
Stephen Margolis, PhD; Kristine M.
Gebbie, DrPH, RN; Andrew Faucett,
MS, CGC; Genetics Competencies for
Public Health Workforce Team
Why GENOMICS
not Genetics
• Genomics is a new evolving term
• Workgroup chose to encourage
“thinking outside the box”
Genetics is currently thought
of in relation to conditions:
• That most people working in public health are
rarely involved with
• Learning genetics had limited value for a
public health career
• Examples include chromosome abnormalities
such as Down syndrome and single gene
mutations such as Cystic Fibrosis or PKU
GENOMICS refers to those
conditions plus ….
• Discoveries from the Human Genome
Project (HGP) which show that most
adult onset and chronic diseases can be
partially caused or prevented by genetic
factors
• Environmental factors also play a
significant role
• Nature and Nurture, not versus
Two Categories
Rare gene / High risk
• Gene frequency usually less than 10%
but risk for disease can be greater than
50%
• HNPCC Colon Cancer
• BRCA 1 and 2 Breast Cancer
• MODY 1,2,3 Diabetes
• Alpha-synuclein Parkinson Disease
Two Categories
Common gene / Moderate risk
• Genes that are very common in the
general population (30-50%) but only
increase the risk moderately and almost
always require environmental factors
and other genes
• ApoE Alzheimer
• Factor V Leiden Stroke / Clotting
• CCR5 HIV/AIDS resistance
Genomics and Public Health
• Human diseases result from gene-environment
interaction
• Public health leadership needed to translate
gene discoveries
• Genetics affects all public health functions:
assessment, policy development and assurance
• Public health must plan to train the workforce in
order to build genetics capacity across programs
Human Genome Project
future impact
• Understand biological basis of diseases
• Predict disease susceptibility before
symptoms
• Interventions targeted to disease biology
• Pharmacotheraphy
• Individualized prevention –
“Individually Sized”
CDC WHO
Genetics Plays a Role in Most
Disease
• Heart Disease
• Cancer
• Stroke
• COPD
• Injury
• Pneumonia / Influenza
• Diabetes
• Suicide
• Kidney Disease
• Chronic Liver Disease
• Heart Disease
• Stroke
• Pneumonia
• HIV / AIDS
• COPD
• Diarrhea
• Perinatal
• Tuberculosis
• Trachea/bronchus/lung
cancer
• Traffic Accidents
Why Now ?
• Technology will produce inexpensive
and efficacious genomic risk tests
• We will have to evaluate relative risk to
the community
• We will have to develop focused
messages to those at high risk
• Consistent with overall public health
workforce initative
Team Leaders
• Laboratory Lou Turner
• Administration Deborah Klein-Walker
• Clinicians Kristine Gebbie / Mary
Ellen Mortensen
• Health Educators Karen Greendale
• Environmentalist Robert Marino
• Epidemiologist Peter D. Rumm
Team Members
Jesse Huang
Bob Fineman
Jan
Friedman
Michele Puryear
Tal Holmes
Luanne
Williams
Steve
Hinricks
Vaughn Upshaw
Richard
Hopkins
Harold
Bengsch
Scott
Zimmerman
Andy
Faucett
Joe Kimbrell
Robert Rolfs
Elaine Krueger
Katherine
Kelly
Kathy
Vincent
Theresa
Long
Jean Chabut
Jennifer
Woodward
Luann White
Frances
Downes
Kathleen
Minor
Alan
Gutmacher
Kathy Peppe
Robert Teclaw
Susan Metcalf
Eric Blank
Karina
Boehm
Elizabeth
Tilson
Robert Jones
Epidemiology
Environmental
Laboratory
Health
Educator
Clinician
Administration
CDC Support
Center for Environmental Health
Office of Genetics
Public Health Practice Program Office
The Process
• Consistent with other competency definition
projects in emerging area of practice
 A combination of expert opinion and consultation with practice field
• Key dates
 March 2000 – Team Leaders Meet
 August 2000 – Teams Meet and Draft 6 Sets
 Drafts Revised & Combined – Email & Conference Call
 March 2001 – Team Leaders Meet – Edit & Cut – Format
 April 2001 – Outside Review by 60+ Associates of Team Members
 May 2001 – Comments Combined – Team Leaders Review by Email
 June 2001 – Document Released on OGDP Web Site
Individual competencies
• Complex combination of knowledge, skills
and abilities demonstrated by organization
members that are critical to the effective
and efficient function of the organization
(Center for Public Health Practice, Emory University).
Competency categories
• All Public Health Workers
• All Professional Workers
• Specialty/Concentration-Specific
 Leaders/administrators
 Clinicians
 Epidemiologists
 Health educators
 Laboratorians
 Environmental health workers
Competency statements have
many uses
• Updating/revising job descriptions
 Do appropriate job descriptions include reference to
genomics
• Employee orientation and training
 As appropriate to program or profession
• Self-assessment by workers
 Am I able to …
All Public Health workers should
• Demonstrate basic knowledge of the
role that genomics has in the
development of disease
• Identify the limits of his/her genomic
expertise
• Make appropriate referrals to those
with more genomic expertise
All Public Health professionals
should
• Apply the basic public health sciences
… utilizing the genomic vocabulary …
• Identify ethical and medical
limitations …
• Maintain knowledge on the
development of genetic advances
• Identify the role of cultural, social,
behavioral, environmental and genetic
factors in … disease
and should
• Participate in strategic policy planning
…
• Collaborate … to solve genomic
related problems
• Participate in the evaluation of …
genomic services in public health
• Develop protocols to insure informed
consent and .. protection
Additionally, as appropriate to
discipline, agency or program
• Leaders / Administrators – 9 more
 e.g., communicate to policy makers
• Clinicians – 5 more
 e.g., apply genomic concepts to clinical
services
• Epidemiology / Data Management – 9
 e.g., accurately describe
sensitivity/specificity of genetics tests
• Health Educators – 7 more
 e.g. differentiate between genomic
education and genetic counselling
• Laboratory – 7 more
 e.g., perform genetic assays with
appropriate validation studies
• Environmental health workers- 6 more
 apply risk communication principles and
genomic knowledge accurately
Genomic Competencies
www.cdc.gov/genetics/
Questions / Comments
Andy Faucett
aif3@cdc.gov
Columbia University
School of Nursing

More Related Content

Similar to Genomics_APHA.ppt

Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
Irene Daniel
 
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
NACCHOpresentations
 
Imp of medical research rsm
Imp of medical research rsmImp of medical research rsm
Probiotic symposium chennai 3 dec 2016
Probiotic symposium chennai 3 dec 2016Probiotic symposium chennai 3 dec 2016
Probiotic symposium chennai 3 dec 2016
neerjayakult
 
prevNcontrol.pptx
prevNcontrol.pptxprevNcontrol.pptx
prevNcontrol.pptx
Khem21
 
Genetic Counseling in the field of medicine.pptx
Genetic Counseling in the field of medicine.pptxGenetic Counseling in the field of medicine.pptx
Genetic Counseling in the field of medicine.pptx
LawalBelloDanchadi
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
Albert Einstein Cancer Center
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
Albert Einstein Cancer Center
 
Session 5.4 Moody
Session 5.4 MoodySession 5.4 Moody
05.4 moody pc
05.4 moody pc05.4 moody pc
The bio psychosocial model of care
The bio psychosocial model of careThe bio psychosocial model of care
The bio psychosocial model of care
Nancy Lutz-Vanderveer
 
GENETIC TESTING:
GENETIC TESTING: GENETIC TESTING:
GENETIC TESTING:
Manisha Thakur
 
Kristen Fessele Webinar 5 16-12
Kristen Fessele Webinar 5 16-12Kristen Fessele Webinar 5 16-12
Kristen Fessele Webinar 5 16-12
Fight Colorectal Cancer
 
2015 Childhood Cancer Symposium: Roadmap for Survivors
2015 Childhood Cancer Symposium: Roadmap for Survivors2015 Childhood Cancer Symposium: Roadmap for Survivors
2015 Childhood Cancer Symposium: Roadmap for Survivors
Alex's Lemonade Stand Foundation
 
Types of research studies, advantages and Disadvantages
Types of research studies, advantages and Disadvantages Types of research studies, advantages and Disadvantages
Types of research studies, advantages and Disadvantages
Mulazim Bukhari
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
Fight Colorectal Cancer
 
Affluent cancers
Affluent cancersAffluent cancers
Affluent cancers
pstrous
 
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEMHEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
Aneesa K Ayoob
 
Epidemiologi pada keperawatan pembelajaran komunitas
Epidemiologi pada keperawatan pembelajaran komunitasEpidemiologi pada keperawatan pembelajaran komunitas
Epidemiologi pada keperawatan pembelajaran komunitas
EliyanaPrasetyo
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptx
WorkuDaba
 

Similar to Genomics_APHA.ppt (20)

Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
 
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
NACCHO 2018 National Conference – Improving the clinical benefits of genetic ...
 
Imp of medical research rsm
Imp of medical research rsmImp of medical research rsm
Imp of medical research rsm
 
Probiotic symposium chennai 3 dec 2016
Probiotic symposium chennai 3 dec 2016Probiotic symposium chennai 3 dec 2016
Probiotic symposium chennai 3 dec 2016
 
prevNcontrol.pptx
prevNcontrol.pptxprevNcontrol.pptx
prevNcontrol.pptx
 
Genetic Counseling in the field of medicine.pptx
Genetic Counseling in the field of medicine.pptxGenetic Counseling in the field of medicine.pptx
Genetic Counseling in the field of medicine.pptx
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
 
Session 5.4 Moody
Session 5.4 MoodySession 5.4 Moody
Session 5.4 Moody
 
05.4 moody pc
05.4 moody pc05.4 moody pc
05.4 moody pc
 
The bio psychosocial model of care
The bio psychosocial model of careThe bio psychosocial model of care
The bio psychosocial model of care
 
GENETIC TESTING:
GENETIC TESTING: GENETIC TESTING:
GENETIC TESTING:
 
Kristen Fessele Webinar 5 16-12
Kristen Fessele Webinar 5 16-12Kristen Fessele Webinar 5 16-12
Kristen Fessele Webinar 5 16-12
 
2015 Childhood Cancer Symposium: Roadmap for Survivors
2015 Childhood Cancer Symposium: Roadmap for Survivors2015 Childhood Cancer Symposium: Roadmap for Survivors
2015 Childhood Cancer Symposium: Roadmap for Survivors
 
Types of research studies, advantages and Disadvantages
Types of research studies, advantages and Disadvantages Types of research studies, advantages and Disadvantages
Types of research studies, advantages and Disadvantages
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
 
Affluent cancers
Affluent cancersAffluent cancers
Affluent cancers
 
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEMHEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
HEALTH ISSUE AS A PUBLIC HEALTH PROBLEM
 
Epidemiologi pada keperawatan pembelajaran komunitas
Epidemiologi pada keperawatan pembelajaran komunitasEpidemiologi pada keperawatan pembelajaran komunitas
Epidemiologi pada keperawatan pembelajaran komunitas
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptx
 

Recently uploaded

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 

Recently uploaded (20)

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 

Genomics_APHA.ppt

  • 1. Columbia University School of Nursing American Public Health Association October 24, 2001 Genetic/Genomic Competencies for Public Health Stephen Margolis, PhD; Kristine M. Gebbie, DrPH, RN; Andrew Faucett, MS, CGC; Genetics Competencies for Public Health Workforce Team
  • 2. Why GENOMICS not Genetics • Genomics is a new evolving term • Workgroup chose to encourage “thinking outside the box”
  • 3. Genetics is currently thought of in relation to conditions: • That most people working in public health are rarely involved with • Learning genetics had limited value for a public health career • Examples include chromosome abnormalities such as Down syndrome and single gene mutations such as Cystic Fibrosis or PKU
  • 4. GENOMICS refers to those conditions plus …. • Discoveries from the Human Genome Project (HGP) which show that most adult onset and chronic diseases can be partially caused or prevented by genetic factors • Environmental factors also play a significant role • Nature and Nurture, not versus
  • 5. Two Categories Rare gene / High risk • Gene frequency usually less than 10% but risk for disease can be greater than 50% • HNPCC Colon Cancer • BRCA 1 and 2 Breast Cancer • MODY 1,2,3 Diabetes • Alpha-synuclein Parkinson Disease
  • 6. Two Categories Common gene / Moderate risk • Genes that are very common in the general population (30-50%) but only increase the risk moderately and almost always require environmental factors and other genes • ApoE Alzheimer • Factor V Leiden Stroke / Clotting • CCR5 HIV/AIDS resistance
  • 7. Genomics and Public Health • Human diseases result from gene-environment interaction • Public health leadership needed to translate gene discoveries • Genetics affects all public health functions: assessment, policy development and assurance • Public health must plan to train the workforce in order to build genetics capacity across programs
  • 8. Human Genome Project future impact • Understand biological basis of diseases • Predict disease susceptibility before symptoms • Interventions targeted to disease biology • Pharmacotheraphy • Individualized prevention – “Individually Sized”
  • 9. CDC WHO Genetics Plays a Role in Most Disease • Heart Disease • Cancer • Stroke • COPD • Injury • Pneumonia / Influenza • Diabetes • Suicide • Kidney Disease • Chronic Liver Disease • Heart Disease • Stroke • Pneumonia • HIV / AIDS • COPD • Diarrhea • Perinatal • Tuberculosis • Trachea/bronchus/lung cancer • Traffic Accidents
  • 10. Why Now ? • Technology will produce inexpensive and efficacious genomic risk tests • We will have to evaluate relative risk to the community • We will have to develop focused messages to those at high risk • Consistent with overall public health workforce initative
  • 11. Team Leaders • Laboratory Lou Turner • Administration Deborah Klein-Walker • Clinicians Kristine Gebbie / Mary Ellen Mortensen • Health Educators Karen Greendale • Environmentalist Robert Marino • Epidemiologist Peter D. Rumm
  • 12. Team Members Jesse Huang Bob Fineman Jan Friedman Michele Puryear Tal Holmes Luanne Williams Steve Hinricks Vaughn Upshaw Richard Hopkins Harold Bengsch Scott Zimmerman Andy Faucett Joe Kimbrell Robert Rolfs Elaine Krueger Katherine Kelly Kathy Vincent Theresa Long Jean Chabut Jennifer Woodward Luann White Frances Downes Kathleen Minor Alan Gutmacher Kathy Peppe Robert Teclaw Susan Metcalf Eric Blank Karina Boehm Elizabeth Tilson Robert Jones Epidemiology Environmental Laboratory Health Educator Clinician Administration
  • 13. CDC Support Center for Environmental Health Office of Genetics Public Health Practice Program Office
  • 14. The Process • Consistent with other competency definition projects in emerging area of practice  A combination of expert opinion and consultation with practice field • Key dates  March 2000 – Team Leaders Meet  August 2000 – Teams Meet and Draft 6 Sets  Drafts Revised & Combined – Email & Conference Call  March 2001 – Team Leaders Meet – Edit & Cut – Format  April 2001 – Outside Review by 60+ Associates of Team Members  May 2001 – Comments Combined – Team Leaders Review by Email  June 2001 – Document Released on OGDP Web Site
  • 15. Individual competencies • Complex combination of knowledge, skills and abilities demonstrated by organization members that are critical to the effective and efficient function of the organization (Center for Public Health Practice, Emory University).
  • 16. Competency categories • All Public Health Workers • All Professional Workers • Specialty/Concentration-Specific  Leaders/administrators  Clinicians  Epidemiologists  Health educators  Laboratorians  Environmental health workers
  • 17. Competency statements have many uses • Updating/revising job descriptions  Do appropriate job descriptions include reference to genomics • Employee orientation and training  As appropriate to program or profession • Self-assessment by workers  Am I able to …
  • 18. All Public Health workers should • Demonstrate basic knowledge of the role that genomics has in the development of disease • Identify the limits of his/her genomic expertise • Make appropriate referrals to those with more genomic expertise
  • 19. All Public Health professionals should • Apply the basic public health sciences … utilizing the genomic vocabulary … • Identify ethical and medical limitations … • Maintain knowledge on the development of genetic advances • Identify the role of cultural, social, behavioral, environmental and genetic factors in … disease
  • 20. and should • Participate in strategic policy planning … • Collaborate … to solve genomic related problems • Participate in the evaluation of … genomic services in public health • Develop protocols to insure informed consent and .. protection
  • 21. Additionally, as appropriate to discipline, agency or program • Leaders / Administrators – 9 more  e.g., communicate to policy makers • Clinicians – 5 more  e.g., apply genomic concepts to clinical services • Epidemiology / Data Management – 9  e.g., accurately describe sensitivity/specificity of genetics tests
  • 22. • Health Educators – 7 more  e.g. differentiate between genomic education and genetic counselling • Laboratory – 7 more  e.g., perform genetic assays with appropriate validation studies • Environmental health workers- 6 more  apply risk communication principles and genomic knowledge accurately
  • 23. Genomic Competencies www.cdc.gov/genetics/ Questions / Comments Andy Faucett aif3@cdc.gov Columbia University School of Nursing